Design and Synthesis of Neutralizable Fondaparinux

[Image: see text] Fondaparinux, a clinically approved anticoagulant pentasaccharide for the treatment of thrombotic diseases, displays better efficacy and biosafety than other heparin-based anticoagulant drugs. However, there is no suitable antidote available for fondaparinux to efficiently manage i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liangwei, Liu, Yating, Xu, Zhuojia, Hao, Tianhui, Wang, Peng George, Zhao, Wei, Li, Tiehai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795572/
https://www.ncbi.nlm.nih.gov/pubmed/36590263
http://dx.doi.org/10.1021/jacsau.2c00537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795572/
https://www.ncbi.nlm.nih.gov/pubmed/36590263
http://dx.doi.org/10.1021/jacsau.2c00537

Ejemplares similares